When was Optomed founded?

Optomed was founded in 2004 and raised its 1st funding round 2 years after it was founded.

Where is Optomed located?

Optomed is headquartered in Alpharetta, United States.

Who is the current CEO of Optomed?

Seppo Kopsala of Optomed. They have also founded 1 company.

How many employees does Optomed have?

As of Mar 31, 2026, the latest employee count at Optomed is 103.

Is Optomed a funded company?

Optomed is a funded company, having raised a total of $4.92M across 5 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Feb 27, 2006.

When was the latest funding round of Optomed?

Optomed's latest funding was a $***** Grant (prize money) round on Jul 31, 2019, with participation from 1 investor.

Where does Optomed rank among its competitors?

Optomed ranks 5th amongst 34 active competitors, of which 11 are funded. It stands 4th in terms of total funding among its competitors. The most recent competitor to raise funding was EarlySight, which secured $3.88M in Sep, 2025.

Who are the top competitors of Optomed?

Optomed's top competitors include Identifeye Health, LKC Technologies and EarlySight. Among them, EarlySight secured the most recent funding round in September, 2025.

Optomed - 2026 Company Profile, Team, Funding & Competitors

Optomed is a public company based in Alpharetta (United States), founded in 2004 by Seppo Kopsala. It operates as a Provider of handheld fundus cameras and software solutions for eye screening. Optomed has raised $4.92M in funding from investors like Mawell, Auratum and Tesi. The company has 34 active competitors, including 11 funded and 6 that have exited. Its top competitors include companies like Identifeye Health, LKC Technologies and EarlySight.

Company Details

Provider of handheld fundus cameras and software solutions for eye screening. The company offers handheld fundus cameras with integrated software and artificial intelligence with the aim to transform the diagnostic process of blinding eye diseases such as diabetic retinopathy and edema.

Website: www.optomed.com/us/
Social
Email ID: *****@optomed.com
Phone Number: +1 **********

Key Metrics

Founded Year

2004

Location

Alpharetta, United States

Stage

Public

Total Funding

$4.92M in 5 rounds

Latest Funding Round

Grant (prize money), Jul 31, 2019, $*****

Investors

Mawell & 7 more

Ranked

5^th among 34 active competitors

Employee Count

103 as on Mar 31, 2026

Investment & Acquisitions

Commit

Similar Companies

Identifeye Health & 44 more

Exit Details

Public

View Optomed's full profile

Optomed is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Optomed Plc CIN: 5790242 , United Kingdom, Active	Aug 12, 2019	-	114 (As on Dec 31, 2022)

Optomed got listed on Dec 05, 2019.

Click here to take a look at Optomed's IPO in detail

Optomed has raised a total funding of $4.92M over 5 rounds. Its first funding round was on Feb 27, 2006. Its latest funding round was a Grant (prize money) round on Jul 31, 2019 for $*****. 1 investor participated in its latest round. Optomed has 8 institutional investors.

Here is the list of recent funding rounds of Optomed:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jul 31, 2019	2718602	Grant (prize money)	2438457	1841241	1908240	4547306
Aug 01, 2017	2029956	Grant (prize money)	5519023	7084751	3352785	Europa
Oct 01, 2015	2871872	Series B	5651933	2725909	9797809	Robert Bosch Venture Capital

Access funding benchmarks and valuations. Sign up today!

View details of Optomed's funding rounds and investors

The founders of Optomed is Seppo Kopsala. Seppo Kopsala is the CEO of Optomed.

Here are the details of Optomed's key team members:

Seppo Kopsala: Founder & CEO of Optomed.
Contact Info: 1 email address

View details of Optomed's Founder profiles and Board Members

Optomed's employee count trend

Optomed has 103 employees as of Mar 26. Here is Optomed's employee count trend over the years:

Uncover Optomed's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Optomed include Identifeye Health, LKC Technologies and EarlySight. Here is the list of Top 10 competitors of Optomed, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Identifeye Health 2016, Guilford (United States), Series B	Developer of a non-invasive test to detect health conditions through the eyes	$80M	Foresite Capital, Hildred & 4 others	58/100
2nd	LKC Technologies 1976, Gaithersburg (United States), Acquired	Visual electrophysiology solutions for assessing retinal function in humans and animals	$3.89M	DW Management Services, Capital Southwest ... & 3 others	56/100
3rd	EarlySight 2016, Lausanne (Switzerland), Seed	Provider of retinal imaging solutions for retinal disorders	$7.64M	Verve Ventures, Nova Capital Management & 9 others	56/100
4th	Heidelberg Engineering 1990, Heidelberg (Germany), Acquired	Provider of diagnostic imaging devices for the early recognition of blindness	-	-	56/100
5th	Optomed 2004, Alpharetta (United States), Public	Provider of handheld fundus cameras and software solutions for eye screening	$4.92M	Robert Bosch Venture Capital, Tech Emerge ... & 6 others	58/100
6th	Oxxius 2002, Lannion (France), Series B	Provider of diversified laser systems	$14.3M	Sofinnova Partners, Sofinnova Investments ... & 4 others	53/100
7th	AEYE Health 2018, New York City (United States), Seed	Provider of AI-based retinal imaging software for diagnosis	$1M	Florida-Israel Business Accelerator	48/100
8th	Olleyes 2018, Summit (United States), Unfunded	Provider of a VR headset for visual field testing of patients	-	-	46/100
9th	RetinalGeniX 2014, United States, Series A	Manufacturer of medical device for diagnosis of diabetic retinopathy	$698K	-	45/100
10th	Diabetik Foot Care India 1991, Chennai (India), Unfunded	Manufacturer of device for detecting diabetic neuropathy	-	-	39/100